CD38‐Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells.

MLA

Liao, Chan, et al. “CD38‐Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells.” Advanced Science, vol. 10, no. 27, Sept. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1002/advs.202207394.

APA

Liao, C., Wang, Y., Huang, Y., Duan, Y., Liang, Y., Chen, J., Jiang, J., Shang, K., Zhou, C., Gu, Y., Liu, N., Zeng, X., Gao, X., Tang, Y., & Sun, J. (2023). CD38‐Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells. Advanced Science, 10(27), 1–16. https://doi.org/10.1002/advs.202207394

Chicago

Liao, Chan, Yajie Wang, Yanjie Huang, Yanting Duan, Yan Liang, Jiangqing Chen, Jie Jiang, et al. 2023. “CD38‐Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells.” Advanced Science 10 (27): 1–16. doi:10.1002/advs.202207394.